6 C
Monday, December 4, 2023
HomeGlobal NewsIzafe Group, in Collaboration With Atea Sweden, Has Won a Procurement Potentially...

Izafe Group, in Collaboration With Atea Sweden, Has Won a Procurement Potentially Worth 42-52 Msek.


Related stories

Dengue is Spreading in Europe: How Worried Should We Be?

The post-COVID travel boom combined with a warm...

Who Voted for WHO?

Toronto, Alaska (16/11 – 50) Our lives are being maneuvered...

Ensuring a Just Europe for All Children

More children are at risk of poverty than...

Europe’s Space Agency Boss Sees Progress on Ariane 6 Launcher

Europe's top space official said on Tuesday there...

There Is a World of Web3 Outside the U.S. and Europe

Upon returning from Token2049 in Singapore, my perceptions...

iZafe Group AB (“iZafe Group”) announces that, in partnership with Atea Sverige AB, they have been awarded a contract with Västra Götalandsregionen for the provision of iZafe’s medication dispensers, Dosell. The contract covers 1,800 units, up to a maximum of 2,250 units, with an estimated value of 42-52 MSEK. The agreement is held by Atea Sverige AB.

The contract term is for two years, with the possibility of a further two-year extension, and the contract will be signed no earlier than after a period of 10 days, which is the time that must elapse after awarding, according to procurement regulations, before a contract can be signed.
This is merely a decision of award and is not legally binding until a contract has been entered into.

iZafe Group is a Life Science company that conducts research, development and marketing of digital medical solutions and services for safer medication management at home.

The company leads the development of digital drug dispensing through the drug robot Dosell as well as the SaaS solution Pilloxa with the smart pillbox. The company’s solutions reduce the risk of incorrect medication in the home, increase compliance, relieve public health care, increase the quality of life for patients and create a safer environment for relatives.

The customers consist of private individuals, pharmaceutical companies and public and private healthcare providers in Sweden, the Nordics and globally. iZafe Group primarily sells through well-established partners who already have long and deep customer relationships with the prioritized customer groups. The head office is in Stockholm.

iZafe Group AB has been listed on the Nasdaq First North Growth Market since 2018. Mangold Fondkommission AB is the company’s Certified Adviser. Further information is available at www.izafegroup.com

Source : Yahoo

Latest stories